{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:00:44Z","timestamp":1785117644852,"version":"3.55.0"},"reference-count":20,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A pheochromocytoma is a rare catecholamine-secreting tumor that can cause life-threatening complications. Circulatory shock with a significant cardiogenic component is an uncommon initial presentation. This case describes a previously healthy 30-year-old woman presenting with vomiting, hyperglycemia, and shock. This rapidly progressed to requiring intubation, vasopressor therapy, and resuscitation following cardiac arrest. Imaging revealed a right adrenal mass and plasma metanephrines and normetanephrines were markedly elevated. After stabilization with \u03b1- and \u03b2-adrenergic blockade, the patient underwent successful adrenalectomy, confirming a pheochromocytoma-induced catecholamine crisis, with full recovery of cardiac function. This case illustrates the diversity of initial presentation of pheochromocytoma, the diagnostic challenges associated with measuring plasma (nor)metanephrines after resuscitation and the reversible nature of catecholamine-induced cardiomyopathy.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag199","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:49:55Z","timestamp":1785116995000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiogenic shock due to pheochromocytoma-induced catecholamine crisis in a young woman"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5785-9753","authenticated-orcid":false,"given":"Thirza","family":"van der Linden","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Maasstad Hospital , 3079 DZ Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Dumont","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maasstad Hospital , 3079 DZ Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Acardag","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maasstad Hospital , 3079 DZ Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0679-6209","authenticated-orcid":false,"given":"Johannes","family":"Hofland","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Section of Endocrinology, Erasmus Medical Center , 3015 GD Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Thijsse","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, Maasstad Hospital , 3079 DZ Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1066-8832","authenticated-orcid":false,"given":"Charlotte","family":"van Noord","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maasstad Hospital , 3079 DZ Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"12","key":"2026072621495064700_luag199-B1","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s40618-025-02639-9","article-title":"Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies","volume":"48","author":"Vitturi","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026072621495064700_luag199-B2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.31083\/j.rcm2204130","article-title":"Catecholamine-induced cardiomyopathy: an endocrinologist's perspective","volume":"22","author":"Kumar","year":"2021","journal-title":"Rev Cardiovasc Med"},{"issue":"50","key":"2026072621495064700_luag199-B3","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002198","article-title":"Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses? A systematic analytical review","volume":"94","author":"Batisse-Lignier","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026072621495064700_luag199-B4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijcard.2017.07.014","article-title":"Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature","volume":"249","author":"Zhang","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026072621495064700_luag199-B5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2023.05.004","article-title":"Pheochromocytoma-induced cardiogenic shock: a multicentre analysis of clinical profiles, management and outcomes","volume":"383","author":"De Angelis","year":"2023","journal-title":"Int J Cardiol"},{"issue":"3","key":"2026072621495064700_luag199-B6","article-title":"Cardiac arrest complicating cardiogenic shock: from pathophysiological insights to Impella-assisted cardiopulmonary resuscitation in a pheochromocytoma-induced Takotsubo cardiomyopathy-a case report","volume":"5","author":"Zilio","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"1","key":"2026072621495064700_luag199-B7","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0735-6757(89)90084-3","article-title":"Pheochromocytoma presenting as shock","volume":"7","author":"Bergland","year":"1989","journal-title":"Am J Emerg Med"},{"issue":"4","key":"2026072621495064700_luag199-B8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4158\/EP11327.OR","article-title":"Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors","volume":"18","author":"Yu","year":"2012","journal-title":"Endocr Pract"},{"issue":"6","key":"2026072621495064700_luag199-B9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1410619","article-title":"Pheochromocytoma in Italy: a multicentric retrospective study","volume":"141","author":"Mannelli","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026072621495064700_luag199-B10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/CRD.0000000000000141","article-title":"Cardiovascular manifestations of pheochromocytoma","volume":"25","author":"Gu","year":"2017","journal-title":"Cardiol Rev"},{"issue":"12","key":"2026072621495064700_luag199-B11","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s40618-022-01868-6","article-title":"Clinical characteristics and outcomes of pheochromocytoma crisis: a literature review of 200 cases","volume":"45","author":"Ando","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026072621495064700_luag199-B12","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026072621495064700_luag199-B13","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/jc.2003-030000","article-title":"Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma","volume":"88","author":"Bl\u00fcher","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026072621495064700_luag199-B14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1124\/jpet.103.049270","article-title":"Sources and significance of plasma levels of catechols and their metabolites in humans","volume":"305","author":"Goldstein","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2026072621495064700_luag199-B15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"6","key":"2026072621495064700_luag199-B16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPA.0b013e3181ebaffd","article-title":"NANETS consensus guidelines for the diagnosis of neuroendocrine tumor","volume":"39","author":"Vinik","year":"2010","journal-title":"Pancreas"},{"issue":"12","key":"2026072621495064700_luag199-B17","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","author":"Eisenhofer","year":"2014","journal-title":"Clin Chem"},{"issue":"7","key":"2026072621495064700_luag199-B18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/CIRCRESAHA.116.308687","article-title":"Acute catecholamine exposure causes reversible myocyte injury without cardiac regeneration","volume":"119","author":"Wallner","year":"2016","journal-title":"Circ Res"},{"issue":"6","key":"2026072621495064700_luag199-B19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.surg.2011.09.001","article-title":"Cardiovascular dysfunction and catecholamine cardiomyopathy in pheochromocytoma patients and their reversal following surgical cure: results of a prospective case-control study","volume":"150","author":"Agarwal","year":"2011","journal-title":"Surgery"},{"issue":"2","key":"2026072621495064700_luag199-B20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00268-022-06731-6","article-title":"Cardiac changes and their reversal following curative surgery in pheochromocytoma: pheoCard prospective cohort study","volume":"47","author":"Vishvak Chanthar","year":"2023","journal-title":"World J Surg"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/8\/luag199\/70134982\/luag199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/8\/luag199\/70134982\/luag199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:49:58Z","timestamp":1785116998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag199\/8742124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag199","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"luag199"}}